1. HARVEY  GROVE HARVEY GROVE United States says:

    By what stretch of the imagination can you justify giving a geriatric patient who is approaching the end of life a drug that can speed up the process? Did the patients know these drugs decreased the length of time these patients could expect to live? How many patients survived the bleeding stroke but had a poorer quality of life plus the extra expense of treatment and rehabilitation, if possible, as a result of this therapy. Does a doctor actually believe this risk is worth trying without informing the patient of the actual risks involved to let the patient decide as to whether or not to take the drugs?

    Is this DEATH AND HANDICAP INDUCING THERAPY USED ONLY AFTER ALL OTHER POSSIBILITIES HAVE FAILED? The cavalier attitude of physicians regarding death as JUST ANOTHER "side effect" can not be condoned. Doctors have been exposed to "side effects" for so long that they developed a "matter of fact"  ATTITUDE TOWARDS DEATH AS JUST ANOTHER "POSSIBILITY" THAT ACCOMPANIES TREATMENT. Is this similar to watching so much death and shooting on TV by our children that makes these children inured to death as long as it is not themselves?

    IT APPEARS FDA AND THE DRUG COMPANIES HAVE FOUND A WAY TO GET EXTREMELY DANGEROUS PRODUCTS ON THE MARKET EVEN THOUGH THEY ARE DEATH PRODUCERS. DOCTORS ENJOY BEATING THE GRIM REAPER, HOWEVER, NOW THEY CAN TRY IT WITHOUT THE GUILT OF KNOWING THEY CAUSED THE DEATH OF THEIR PATIENT AS IT IS ONLY A "SIDE EFFECT".

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.